Mumbai, Baltimore, June 03, 2023: Global pharma major Lupin Limited today announced the launch of Darunavir Tablets 600 mg and 800 mg to market a generic equivalent of Prezista®. | June 3, 2023
Mumbai, Baltimore, June01, 2023: Global pharma major Lupin Limited today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has. | June 1, 2023
Mumbai, Baltimore, May31, 2023: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its. | May 31, 2023
In the last 10 years, PR has taken a different dimension, especially after the entry of social media and the rapid shift to digital during the pandemic period.
First Biosimilar for Head and Neck Cancer Treatment Mumbai, May 30, 2023: Global pharma major Lupin Limited today announced a strategic collaboration with Enzene. | May 30, 2023